-
1
-
-
0036829816
-
Natural history of chronic hepatitis C
-
Seeff LB. Natural history of chronic hepatitis C. Hepatology. 2002; 36(5 Suppl 1):S35-46.
-
(2002)
Hepatology
, vol.236
, Issue.5 SUPPL. 1
-
-
Seeff, L.B.1
-
2
-
-
14644390213
-
The liver biopsy in chronic hepatitis C: A view from the other side of the microscope
-
Kleiner DE. The liver biopsy in chronic hepatitis C: a view from the other side of the microscope. Semin Liver Dis. 2005; 25(1):52-64.
-
(2005)
Semin Liver Dis
, vol.25
, Issue.1
, pp. 52-64
-
-
Kleiner, D.E.1
-
3
-
-
79951679699
-
First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy
-
Poynard T. First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy. J Hepatol. 2011; 54(3):586-7.
-
(2011)
J Hepatol
, vol.54
, Issue.3
, pp. 586-587
-
-
Poynard, T.1
-
4
-
-
67650188604
-
Non-invasive biomarkers for monitoring the fibrogenic process in liver: A short survey
-
Gressner AM, Gao CF, Gressner OA. Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey. World J Gastroenterol. 2009; 1520): 2433-40.
-
(2009)
World J Gastroenterol
, vol.1520
, pp. 2433-2440
-
-
Gressner, A.M.1
Gao, C.F.2
Gressner, O.A.3
-
5
-
-
77953321632
-
Circulating markers of liver fibrosis progression
-
Jarcuska P, Janicko M, Veseliny E, Skladany L. Circulating markers of liver fibrosis progression. Clin Chim Acta. 2010; 411(15-16):1009-17.
-
(2010)
Clin Chim Acta
, vol.411
, Issue.15-16
, pp. 1009-1017
-
-
Jarcuska, P.1
Janicko, M.2
Veseliny, E.3
Skladany, L.4
-
6
-
-
33745477366
-
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy
-
Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol. 2006; 1223): 3682-94.
-
(2006)
World J Gastroenterol
, vol.1223
, pp. 3682-3694
-
-
Sebastiani, G.1
Alberti, A.2
-
7
-
-
68949205020
-
Systematic review: Non-invasive methods of fibrosis analysis in chronic hepatitis C
-
Smith JO, Sterling RK. Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. Aliment Pharmacol Ther. 2009; 30(6):557-76.
-
(2009)
Aliment Pharmacol Ther
, vol.30
, Issue.6
, pp. 557-576
-
-
Smith, J.O.1
Sterling, R.K.2
-
8
-
-
0029000625
-
Serum hyaluronan as a marker of liver fibrosis
-
Guechot J, Poupon RE, Poupon R. Serum hyaluronan as a marker of liver fibrosis. J Hepatol. 1995; 22(2 Suppl):103-6.
-
(1995)
J Hepatol
, vol.22
, Issue.2 SUPPL.
, pp. 103-106
-
-
Guechot, J.1
Poupon, R.E.2
Poupon, R.3
-
9
-
-
13244255642
-
Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease
-
Saitou Y, Shiraki K, Yamanaka Y, Yamaguchi Y, Kawakita T, Yamamoto N, et al. Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease. World J Gastroenterol. 2005; 11(4):476-81.
-
(2005)
World J Gastroenterol
, vol.11
, Issue.4
, pp. 476-481
-
-
Saitou, Y.1
Shiraki, K.2
Yamanaka, Y.3
Yamaguchi, Y.4
Kawakita, T.5
Yamamoto, N.6
-
10
-
-
73649120926
-
Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: A comparative analysis of nine scoring methods
-
Ladero JM, Delkader J, Ortega L, Fernandez C, Devesa MJ, Lopez-Alonso G, et al. Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: a comparative analysis of nine scoring methods. Scand J Gastroenterol. 2010; 45(1):51-9.
-
(2010)
Scand J Gastroenterol
, vol.45
, Issue.1
, pp. 51-59
-
-
Ladero, J.M.1
Delkader, J.2
Ortega, L.3
Fernandez, C.4
Devesa, M.J.5
Lopez-Alonso, G.6
-
11
-
-
0035820265
-
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study
-
Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet. 2001; 357(9262):1069-75.
-
(2001)
Lancet
, vol.357
, Issue.9262
, pp. 1069-1075
-
-
Imbert-Bismut, F.1
Ratziu, V.2
Pieroni, L.3
Charlotte, F.4
Benhamou, Y.5
Poynard, T.6
-
12
-
-
9644279531
-
Serum markers detect the presence of liver fibrosis: A cohort study
-
Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology. 2004; 127(6):1704-13.
-
(2004)
Gastroenterology
, vol.127
, Issue.6
, pp. 1704-1713
-
-
Rosenberg, W.M.1
Voelker, M.2
Thiel, R.3
Becka, M.4
Burt, A.5
Schuppan, D.6
-
13
-
-
77649279553
-
A meta-analysis of transient elastography for the detection of hepatic fibrosis
-
Stebbing J, Farouk L, Panos G, Anderson M, Jiao LR, Mandalia S, et al. A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol. 2010; 44(3):214-9.
-
(2010)
J Clin Gastroenterol
, vol.44
, Issue.3
, pp. 214-219
-
-
Stebbing, J.1
Farouk, L.2
Panos, G.3
Anderson, M.4
Jiao, L.R.5
Mandalia, S.6
-
14
-
-
78049485434
-
Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study)
-
Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, Voitot H, et al. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol. 2010; 53(6):1013-21.
-
(2010)
J Hepatol
, vol.53
, Issue.6
, pp. 1013-1021
-
-
Degos, F.1
Perez, P.2
Roche, B.3
Mahmoudi, A.4
Asselineau, J.5
Voitot, H.6
-
15
-
-
33646139892
-
Liver fibrosis: Noninvasive diagnosis with double contrast materialenhanced MR imaging
-
Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB. Liver fibrosis: noninvasive diagnosis with double contrast materialenhanced MR imaging. Radiology. 2006; 239(2):425-37.
-
(2006)
Radiology
, vol.239
, Issue.2
, pp. 425-437
-
-
Aguirre, D.A.1
Behling, C.A.2
Alpert, E.3
Hassanein, T.I.4
Sirlin, C.B.5
-
16
-
-
38649113882
-
Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications
-
Talwalkar JA, Yin M, Fidler JL, Sanderson SO, Kamath PS, Ehman RL. Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology. 2008; 47(1):332-42.
-
(2008)
Hepatology
, vol.47
, Issue.1
, pp. 332-342
-
-
Talwalkar, J.A.1
Yin, M.2
Fidler, J.L.3
Sanderson, S.O.4
Kamath, P.S.5
Ehman, R.L.6
-
17
-
-
77954846408
-
Novel biomarkers predict liver fibrosis in hepatitis C patients: Alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI
-
Ho AS, Cheng CC, Lee SC, Liu ML, Lee JY, Wang WM, et al. Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI. J Biomed Sci. 2010; 17:58.
-
(2010)
J Biomed Sci
, vol.17
, pp. 58
-
-
Ho, A.S.1
Cheng, C.C.2
Lee, S.C.3
Liu, M.L.4
Lee, J.Y.5
Wang, W.M.6
-
18
-
-
79955806309
-
New approaches for biomarker discovery: The search for liver fibrosis markers in hepatitis C patients
-
Gangadharan B, Antrobus R, Chittenden D, Rossa J, Bapat M, Klenerman P, et al. New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients. J Proteome Res. 2011; 10(5):2643-50.
-
(2011)
J Proteome Res
, vol.10
, Issue.5
, pp. 2643-2650
-
-
Gangadharan, B.1
Antrobus, R.2
Chittenden, D.3
Rossa, J.4
Bapat, M.5
Klenerman, P.6
|